FDA Reclassifies Several Peptides — A Practical Guide for Research Buyers
The FDA’s recent removal of multiple peptides from Category 2 changes compounding eligibility but not drug approval; researchers should focus on sourcing, testing, and documentation when purchasing peptides for lab use.
May 18, 2026









